Home
Browse
Search
Statistics
About
Usage
PMID: 22672057
Keeling KM, Wang D, Conard SE, Bedwell DM
Suppression of premature termination codons as a therapeutic approach.
Crit Rev Biochem Mol Biol. 2012 Sep;47(5):444-63. doi: 10.3109/10409238.2012.694846. Epub 2012 Jun 7.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
218
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:218:4
status:
NEW
view ABCC7 p.Gly542* details
The
G542X
mutation, found in 2% of Caucasian CF patients, is the most common CFTR nonsense mutation.
Login to comment
224
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 22672057:224:4
status:
NEW
view ABCC7 p.Gly551Asp details
The
G551D
mutation, a CFTR gating mutant found in approximately 4% of CF patients, is an example of this mutation class. Class IV is made up of mutations that allow correct CFTR localization and activation by cAMP, but with reduced chloride conductance.
Login to comment
234
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:234:133
status:
NEW
view ABCC7 p.Gly542* details
Studies to examine suppression of a CFTR nonsense mutation utilized a transgenic mouse that carried a human CFTR cDNA containing the
G542X
nonsense mutation.
Login to comment
236
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:236:9
status:
NEW
view ABCC7 p.Gly542* details
The CFTR-
G542X
transgene was then crossed into a Cftrtm1Cam knockout mouse, resulting in a mouse that was suitable to evaluate the ability of suppression therapy to restore CFTR protein function (Du et al., 2002).
Login to comment
244
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:244:74
status:
NEW
view ABCC7 p.Gly542* details
In summary, a number of different drugs were found to suppress the common
G542X
mutation in a transgenic CF mouse model.
Login to comment
395
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 22672057:395:196
status:
NEW
view ABCC7 p.Gly551Asp details
VX-809 was developed for CF patients with the Class II mutation F508del that affects CFTR trafficking (Van Goor et al., 2011), and VX-770 (Kalydeco&#ae; ) was developed for the Class III mutation
G551D
that produces correctly localized CFTR, but causes channel gating defects (Van Goor et al., 2009).
Login to comment
518
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:518:97
status:
NEW
view ABCC7 p.Gly542* details
Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-
G542X
transgene.
Login to comment
521
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:521:80
status:
NEW
view ABCC7 p.Gly542* details
Clinical doses of amikacin provide more effective suppression of the human CFTR-
G542X
stop mutation than gentamicin in a transgenic CF mouse model.
Login to comment
524
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:524:86
status:
NEW
view ABCC7 p.Gly542* details
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-
G542X
nonsense allele in a CF mouse model.
Login to comment
531
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 22672057:531:87
status:
NEW
view ABCC7 p.Gly542* details
Poly-l-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-
G542X
mutation in a cystic fibrosis mouse model.
Login to comment